A detailed history of Safeguard Investment Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Safeguard Investment Advisory Group, LLC holds 1,850 shares of ABBV stock, worth $313,815. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,850
Previous 1,307 41.55%
Holding current value
$313,815
Previous $224,000 62.95%
% of portfolio
0.1%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $88,965 - $108,236
543 Added 41.55%
1,850 $365,000
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $202,310 - $236,253
1,307 New
1,307 $224,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $217,782 - $250,809
1,506 New
1,506 $240,000
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $61,380 - $67,572
-600 Closed
0 $0
Q4 2020

Feb 18, 2021

BUY
$80.49 - $108.67 $48,294 - $65,202
600 New
600 $64,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Safeguard Investment Advisory Group, LLC Portfolio

Follow Safeguard Investment Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Safeguard Investment Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Safeguard Investment Advisory Group, LLC with notifications on news.